Home > Boards > US Listed > Medical - Equipment >

Ekso Bionics Holdings, Inc. (EKSO)

Add EKSO Price Alert      Hide Sticky   Hide Intro
Moderator: skepticone, Lion33, Rhetorical
Search This Board: 
Last Post: 1/17/2018 1:04:22 PM - Followers: 113 - Board type: Free - Posts Today: 4

Industry leaders in healthcare, military, and industrial exoskeletons 
                                         (Continue below to message board)                                  


Ekso GT (Healthcare):

Ekso GT is a robotic exoskeleton used for over-ground gait training in people with a neurological diagnosis. It helps patients re-learn the correct step patterns and weight shifts involved in walking, potentially mitigating compensatory behaviors.

Ekso GT’s Variable Assist software allows physical therapists to determine how much power is provided to either side of the person’s body. This balances the physical effort that the person exerts with the amount of help that he or she needs to achieve a more normalized gait. It also makes the device suitable for a broad spectrum of neuro-rehabilitation activities and keeps individuals challenged as they progress through their rehabilitation.

For people who thought they would never stand or walk again, Ekso GT provides hope for greater mobility and independence.

[Christina Kwasnica, M.D., medical director for the Barrow Neuro Rehabilitation Center, notes, “The robotic device allows us to get patients up on their feet earlier. The gains we see are overwhelming and the positive effects on a patient’s mood and motivation is unbelievable.”

Ekso Bionics(TM) Receives Its First NIH Grant (Oct 28, 2014):
RICHMOND, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.

Ekso Bionics Licences Intellectual Property to Ottobock (Nov 3, 2014):

Ekso GT™ Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients (Apr 4, 2016):

EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology (Jun 7, 2016):

Ekso Bionics® Launches Smart Assist (Oct 4, 2016):

Ekso Bionics® Launches EksoPulse Cloud-Based Analytics (Feb 9, 2017):

Ekso Bionics and Vodafone Receive 2016 HealthTechZone Telehealth Award (Apr 7, 2017):

Ekso: T.A.L.O.S. & Warrior Web (D.O.D.):

T.A.L.O.S. (Tactical Assault LIght Operator Suit):
Ekso Labs was awarded an Other Transaction for Prototypes Agreement from U.S. Special Operations Command (SOCOM) to develop technologies for their Tactical Assault Light Operator Suit (TALOS) project. TALOS is a futuristic assault suit that promises to provide superhuman strength with superior mobility and protection, and is often referred to as the "Iron Man" suit. The exoskeleton chassis, which Ekso Labs is developing, will be designed to allow soldiers to carry out their mission with agility, while carrying hundreds of pounds of load. The TALOS project is integrating other functional elements, including armor and systems, to provide situational awareness and technology for vital signs monitoring.

Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project

Ekso(TM) Labs Secures Third Contract With the U.S. Special Operations Command (SOCOM) for Upper Extremity TALOS Project (5/20/15)

Warrior Web Flexible Exoskeleton:
Ekso Bionics™ Selected for Development of Next-Generation DARPA Exoskeleton

Warrior Web A:
Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported.

Warrior Web B:

"Ekso Bionics (NASDAQ: EKSO), having successfully supplied technology to Warrior Web Task A, has been selected to participate in the second and concluding Warrior Web Task B.

Ekso Bionics will gain $4.5 million in the combined contract for both tasks." - RBR

Army R&D with RE2 Robotics:
(This is from a press release from RE2, not from Ekso Bionics. Ekso is simply jointly involved as mentioned below)
Note: EKSO is now on the NASDAQ exchange not the OTCBB

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."


EksoZeroG and Artemis (Construction/Tool Usage):


Ekso Bionics has spent several years designing and perfecting a range of ergonomic tool arms which are used to weightlessly manoeuvre heavy tools. These arms rely on spring tension and innovative design to balance the weight of tools used in drilling, sanding, riveting and many other applications. The Ekso Bionics Zero G arms are designed to hold loads of up to 19kg and fully balance the weight thus allowing the user to freely, safely and accurately manoeuvre the load in any direction without injury or fatigue.

The ergonomic tool arms have a variety of mounting options to suit the application including portable gantry’s, carts, jib arms, and linear rail. These systems require very little maintenance, no expensive inputs like electricity or compressed air, and have already been successfully used in a variety of industries from aerospace and defence to automotive manufacturing.

  • -Payback of less than a year
    -ROI of 100%
    -Less than 30 min of operator training required to achieve competency
    -No expensive inputs such as electricity or air required
    -Very minimal maintenance
    -Modular design for flexibility
    -13 different mobile and fixed mounting options
    -4 different arm configurations

There are several mounting options fro the Zero G ergonomic tool arms from ground based trolleys, to gantry mounts, jib crane mounts, linear rail and bench top mounting.

The Zero G ergonomic tool arm is used extensively in the aerospace,construction, mining and ship building industries in a range of roles. The weight balancing aspect of the Equipois Zero G system allows workers to grind, drill, chip surfaces easily for long periods of time even if the surface is in an overhead orientation.

Current users of the Equipois Zero G system include Airbus, Boeing, General Electric, BHP Billiton, Gammon Construction, Lockheed Martin, Chrysler, Ford, Honda, Nissan, Toyota, Caterpillar, John Deere, Bradken and many more.


Ekso Artemis:

"RICHMOND, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an exoskeleton company, today announced that it has completed the development of a lightweight, flexible load carriage exoskeleton prototype named Artemis."

Ekso Bionics Company Information:
-Founded in 2005 and headquartered in Richmond, CA 
--Originally Berkely Bionics of Univsity of California, Berkeley
-The current CEO is Thomas Loobyy
-Ekso is the industry leader in healthcare, military, and industrial exoskeletons
-The Ekso Bionics Ekso GT™ is the first and only FDA approved exoskeleton for stroke rehabiliation
-Over 190 international patent cases (granted or pending)

-Headquartered in the historic Ford Motor Company Assembly Plant, the largest wartime production assembly plant to be built on the West Coast
Company Presentation:

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested. There are no guarantees when buying or selling any security.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EKSO News: Current Report Filing (8-k) 01/09/2018 08:16:26 AM
EKSO News: Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results 01/09/2018 08:00:00 AM
EKSO News: Harwood Feffer LLP Announces Investigation of Ekso Bionics Holdings, Inc. 01/08/2018 04:23:00 PM
EKSO News: Current Report Filing (8-k) 12/27/2017 04:38:31 PM
EKSO News: Amended Quarterly Report (10-q/a) 12/27/2017 04:37:06 PM
#2381  Sticky Note On Talos: [continued "top level support" for the Rhetorical 08/16/16 07:02:33 PM
#4872   This stock is allergic to 2 bucks. kpisme 01/17/18 01:04:22 PM
#4871 PennyWorld 01/17/18 11:36:39 AM
#4870   I agree 100% with everything you wrote Porsche! Bobby Marinov 01/17/18 11:19:24 AM
#4869   Bobby, I have to respectfully disagree, these are Porsche911guy 01/17/18 09:24:09 AM
#4868   I know that Ekso did not go to Bobby Marinov 01/16/18 07:45:31 PM
#4867 PennyWorld 01/16/18 05:04:21 PM
#4866   Thanks Bobby, the link says a lot. But Porsche911guy 01/16/18 04:54:34 PM
#4865   What would you like to know about WearRAcon18 Bobby Marinov 01/16/18 03:48:16 PM
#4864   This is multi billion dollar market being created. packerfan9 01/16/18 01:43:33 PM
#4863 skepticone 01/16/18 12:58:30 PM
#4862   Great Find Skeptic, the 11:55 vid is the Porsche911guy 01/16/18 12:35:42 PM
#4861 skepticone 01/16/18 11:52:24 AM
#4860   Skeptic, Great question, my theory is some of these Porsche911guy 01/16/18 11:31:10 AM
#4859   Unless we have closes above 2.00, the 50 skepticone 01/16/18 10:56:06 AM
#4858   Porsche...Can you take a look at something for skepticone 01/16/18 10:46:35 AM
#4857   Hello EKSO Longs, quick update on the charts. Porsche911guy 01/16/18 09:34:42 AM
#4856   FORTIS seems to be making progress, remember Ekso Rhetorical 01/15/18 10:38:09 PM
#4855   I'm not at all worried about any potential Rhetorical 01/15/18 10:37:20 PM
#4854   For what's it's worth, I've seen this happen PennyWorld 01/15/18 02:07:01 PM
#4853   Hi all, AIrvani 01/15/18 01:37:29 PM
#4852   Shows like I said this is just starting. packerfan9 01/11/18 04:16:02 PM
#4851 skepticone 01/11/18 09:50:59 AM
#4850   This post response may be out of sequence. PennyWorld 01/10/18 07:24:17 PM
#4849   Well, my CPA tax guy has been letting PennyWorld 01/10/18 07:16:53 PM
#4848   I did not know that, as a matter skepticone 01/10/18 06:22:41 PM
#4847   That is partially correct. PennyWorld 01/10/18 06:20:13 PM
#4846   The point I was trying to make was skepticone 01/10/18 06:16:07 PM
#4845   Am I correct in saying that the only skepticone 01/10/18 06:03:11 PM
#4844 skepticone 01/10/18 05:56:10 PM
#4843   For me, my response is so simple that PennyWorld 01/10/18 05:51:24 PM
#4842   I have a question for you. THIS IS skepticone 01/10/18 01:46:17 PM
#4841   Good to see that you got in before skepticone 01/10/18 10:05:59 AM
#4840   EKSO was a technical signal on one of PennyWorld 01/10/18 09:50:06 AM
#4839   Back to showing + .01 at the open skepticone 01/10/18 09:32:24 AM
#4838   This morning's pre-market action looks to be reacting skepticone 01/10/18 08:52:54 AM
#4837 you currently have a position in EKSO? skepticone 01/10/18 08:42:20 AM
#4836   I agree. I've learned that the big PennyWorld 01/09/18 09:18:45 PM
#4835   I think institutions take a day or two Rhetorical 01/09/18 07:31:57 PM
#4834   Thank you abira, those were the comparisons I skepticone 01/09/18 06:50:49 PM
#4833   Agreed packerfan9 01/09/18 05:57:17 PM
#4832   If we look at the current ER within abira 01/09/18 05:46:56 PM
#4831   Closing green doesn't necessarily mean the market likes skepticone 01/09/18 05:08:20 PM
#4830   I like revenue increase and closing green says packerfan9 01/09/18 04:41:09 PM
#4829   My read on the reaction to the preliminary skepticone 01/09/18 03:45:27 PM
#4828   Rebuttal. I'm sorry, but those rich, fat PennyWorld 01/09/18 02:19:34 PM
#4827   Here's my take on the preliminary #'s IMO: Porsche911guy 01/09/18 01:08:44 PM
#4826   And trust me, Ford pays each of wildwertski 01/09/18 11:45:12 AM
#4825   Thanks. This was actually a very helpful PennyWorld 01/09/18 11:17:58 AM
#4824   4q preliminary out golfblues 01/09/18 08:24:31 AM
#4823   In my opinion, at this time it will Lion33 01/09/18 07:54:56 AM